Related Experiment Video

Updated: Jun 10, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

Long-term LDL-c lowering in heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness

S Sivapalaratnam1, L L van Loendersloot, B A Hutten

  • 1Department of Vascular Medicine, Academic Medical Centre, F4-159.2, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. s.sivapalaratnam@amc.uva.nl

Atherosclerosis
|July 27, 2010
PubMed

Insights

Long-term statin therapy effectively normalizes carotid intima-media thickness (cIMT) in familial hypercholesterolemia (FH) patients, suggesting a significant reduction in cardiovascular disease risk for this high-risk group.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to extremely high LDL-cholesterol levels and premature cardiovascular disease.
  • Statins are the cornerstone of lipid-lowering therapy, but their impact on subclinical atherosclerosis markers in FH requires further investigation in real-world settings.

Purpose of the Study:

  • To evaluate the effectiveness of long-term statin treatment in reducing arterial wall thickness, measured by carotid intima-media thickness (cIMT).
  • To compare cIMT between statin-treated FH patients and their unaffected relatives (spouses) to assess treatment impact.

Main Methods:

  • An observational study included 40 FH patients on statins for ≥5 years and their 40 unaffected spouses.
  • Carotid intima-media thickness (cIMT) was measured as a surrogate marker for atherosclerosis.
  • Clinical data, including lipid profiles, were collected and analyzed.

Main Results:

  • FH patients and spouses had similar LDL-cholesterol (3.8 vs. 3.5 mmol/L) and total cholesterol levels (5.8 vs. 5.6 mmol/L) at the time of assessment.
  • Multivariate analysis showed no significant difference in cIMT between FH patients and their spouses after adjusting for age and sex (p=0.34).

Conclusions:

  • Long-term statin treatment appears to normalize cIMT in FH patients, bringing it to levels comparable to unaffected individuals.
  • This normalization suggests that statin therapy significantly mitigates the accelerated atherosclerosis and extreme cardiovascular risk associated with FH.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...